ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Titan Cement International SA

Titan Cement International SA (TITC)

43.50
0.00
(0.00%)
Closed 30 January 2:20AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
43.50
Bid
43.60
Offer
43.65
Volume
124,390
43.10 Day's Range 44.50
0.00 52 Week Range 0.00
Previous Close
43.50
Open
43.45
Last Trade
75
@
43.65
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TITC Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

TITC - Frequently Asked Questions (FAQ)

What is the current Titan Cement share price?
The current share price of Titan Cement is 43.50 €
What is the 1 year trading range for Titan Cement share price?
Titan Cement has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRDProodeftiki R
0.356 €
(9.88%)
38.52k
MPITRBitros R
0.645 €
(9.32%)
5.12k
ATEKAttica Public R
1.03 €
(8.99%)
20.13k
HAIDEHaidemenos R
0.59 €
(7.27%)
122
MASTIHAMediterra SA
1.43 €
(5.93%)
500
VIDAVOVidavo SA
2.80 €
(-9.68%)
283
BIOTBioter SA
0.226 €
(-9.60%)
9.98k
KAREKarelia Tobacco Company Inc SA
328.00 €
(-6.29%)
396
PAIRE Pairis R
1.035 €
(-5.91%)
1.19k
MOYZKEl D Mouzakis SA
0.63 €
(-4.55%)
1.14k
ALPHAAlpha Services and Holdings SA
1.81 €
(1.37%)
9.32M
EUROBEurobank Ergasias Services and Holdings SA
2.432 €
(0.33%)
3.34M
TPEIRPiraeus Financial Holdings SA
4.451 €
(-0.25%)
2.96M
ETENational Bank of Greece
8.384 €
(-0.19%)
2.36M
TATTAttica Bank SA
0.76 €
(-1.30%)
1.09M

Discussion

View Full Feed
Backstabbed Backstabbed 5 minutes ago
25,000 shares x $0.20 = $5,000 USD
ZHUD
newmedman newmedman 5 minutes ago
Hold on to the truth…
A recording from Jim Acosta's Substack live video
JIM ACOSTA
JAN 28, 2025
It was early March in 2007 when I received a phone call in the middle of the night. CNN’s bureau chief in New York at the time, Edith Chapin, called to deploy me to the Bronx o
MartinLutherKing MartinLutherKing 5 minutes ago
https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors?
RNAZ
valuemind valuemind 5 minutes ago
2025-2027 will be TSLA years!
TSLA
jondoeuk jondoeuk 6 minutes ago
The PR is an utter mess! The ORR across subgroups is higher, but the (m)PFS isn't that great.
FATE
MartinLutherKing MartinLutherKing 6 minutes ago
FDA Approves TransCode's Phase 1/2 Trial of TTX-MC138 for Advanced Solid Tumors
18 April 2024
3 min read
TransCode Therapeutics, Inc., a specialist in RNA oncology, has revealed that the U.S. Food and Drug Administration has finished reviewing their Investigational New Drug appl
RNAZ
Backstabbed Backstabbed 7 minutes ago
50,000 shares x $0.20 = $10,000 USD
ZHUD
Backstabbed Backstabbed 8 minutes ago
100,000 shares x $0.20 = $20,000 USD
ZHUD
Backstabbed Backstabbed 8 minutes ago
250,000 shares x $0.20 = $50,000 USD
ZHUD
ChartTRACKER ChartTRACKER 8 minutes ago
$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.
ADTX
Backstabbed Backstabbed 9 minutes ago
500,000 shares x $0.20 = $100,000
ZHUD
Techroemancer Techroemancer 9 minutes ago
Hopefully the momentum of the volume will continue to uptick. With the current O/S, we need some big volume days to get us out of the trips land. The financials and performance are phenomenal and once we can gain some traction/momentum, this should be easy to launch. Just need the interest/volume an
ASII
MartinLutherKing MartinLutherKing 9 minutes ago
TTX-MC-138 targets miR-10b and has potential applications in the treatment of various cancers and diseases affecting different body systems. The drug is currently in Phase 1/2 of development and has been designated as an orphan drug, indicating its potential to address unmet medical needs in rare di
RNAZ
zab zab 9 minutes ago
Trump's pandemic killed 1.3 million Americans,  you must be so happy with his choice to downplay it.
Backstabbed Backstabbed 9 minutes ago
1,000,000 shares x $0.20 = $200,000 USD
ZHUD
Backstabbed Backstabbed 10 minutes ago
Cohen said $0.20 by May 2025! $ZHUD
ZHUD
stealofadeal stealofadeal 10 minutes ago
$KRTL Another good day today. Thin share structure and going to move fast.
KRTL
bb8675309 bb8675309 10 minutes ago
Hey Bourbon. Good to hear from you. Yes, it would be great if they brought back the uptick rule. Might help. Maybe that's the way market shorting was once done and is intended to work but today shorts are destroying good companies. I don't believe the retail investor has SEC protection in the market
AVXL
Whalatane Whalatane 10 minutes ago
Ha ha ...hope not . Usually analysts give 1 yr targets
Co will be hosting a commercialization day this Qt I think ...to show they are ready to launch as soon as approved
Kiwi
UNCY
Ex-brokerBry Ex-brokerBry 10 minutes ago
Ok Georgie18,do you have any idea who that seller is.?When will this end.Stocks have a tendency to go down slowly and then rise guickly.My Morgan Stanley has a final price after that 1 milly buy at the end at .0457....I've been burned with these kind of stocks.If it drops below .03 I'm buying more.Y
UMAV
jondoeuk jondoeuk 10 minutes ago
We won't know until it is tested, but from this: 'We found activated CD19 CAR.ADR T cells have lower levels of detectable 4-1BB on their surface compared to CD19 CAR T cells, suggesting partial downregulation or masking of 4-1BB upon ADR expression (Supplementary Fig. 9a). Indeed, expression of a tr
FATE
nowwhat2 nowwhat2 11 minutes ago
What a performance eh ?.......How's about THAT ?

https://investorshub.advfn.com/uimage/uploads/2025/1/29/bghbxBTC_!_29_15d_930am_fomc_deep_import.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/29/ipgjvbtc_!_29_15d_2pm_FOMC_update_100k.jpg
valuemind valuemind 11 minutes ago
NXT outperformed FSLR nearly 50% in the past 3 months. Stock selection is apparently more important than industry selection.
FSLR NXT

Your Recent History

Delayed Upgrade Clock